Single award · contract
Advanced Development of Nitazoxanide, Administered Alone or in Combination with Oseltamivir, for Treatment of…
Award ID: HHSO100201300004C
A single federal award, with both ends of the trail linked.
$70.7M
Total award value
Award HHSO100201300004C is a contract from the Department of Health and Human Services, $70.7M obligated, FY2013 to FY2016, for Advanced Development of Nitazoxanide, Administered Alone or in Combination with Oseltamivir, for…. The work is performed in Florida. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC AN11 (Health R&D Services; Health Care Services; Basic Research). Source
Description
Igf::ot::igf Advanced Development of Nitazoxanide, Administered Alone or in Combination with Oseltamivir, for Treatment of Acute Uncomplicated Influenza Virus Infection in Adults and Pediatric Patients at Least 12 Years of Age
Award details
Award typeContract
PIIDHHSO100201300004C
Action date2013
Period34 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceFlorida →
CategoryNAICS 325412PSC AN11
Competed?Not recordedSource
Total (exact)$70,748,205
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.